Getting your Trinity Audio player ready...
DeKalb bounty: DeKalb Genetics Corp. said fiscal second-quarter earnings rose 18 percent, topping expectations, as strong sales from the seed company’s Argentina unit offset a decline in U.S. sales caused by delayed corn-seed shipments from South America. Net income in the quarter ended Feb. 28 rose to $19.3 million, or 53 cents a diluted share, from $16.3 million, or 46 cents, in the year-ago period. Revenue rose 11 percent to $213.8 million from $192.3 million. The results exceeded expectations of 44 cents a share, the average estimate of analysts surveyed by IBES. DeKalb shares rose $2.50 to $71 in morning trading.
